141 related articles for article (PubMed ID: 26298174)
1. Vaccination strategies in lymphoproliferative disorders: Failures and successes.
Allegra A; Russo S; Gerace D; Calabrò L; Maisano V; Innao V; Musolino C
Leuk Res; 2015 Oct; 39(10):1006-19. PubMed ID: 26298174
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
3. Cancer immune therapy for lymphoid malignancies: recent advances.
Klausen U; Jørgensen NGD; Grauslund JH; Holmström MO; Andersen MH
Semin Immunopathol; 2019 Jan; 41(1):111-124. PubMed ID: 30006739
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccine for lymphoma.
Lee ST; Neelapu SS; Kwak LW
Yonsei Med J; 2007 Feb; 48(1):1-10. PubMed ID: 17326239
[TBL] [Abstract][Full Text] [Related]
5. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
Mittal S; Marshall NA; Barker RN; Vickers MA
Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
8. Active and passive immunotherapy for lymphoma: proving principles and improving results.
Brody J; Kohrt H; Marabelle A; Levy R
J Clin Oncol; 2011 May; 29(14):1864-75. PubMed ID: 21482977
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
10. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
11. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.
Aguilar LK; Guzik BW; Aguilar-Cordova E
J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529
[TBL] [Abstract][Full Text] [Related]
13. Current vaccination strategies for prostate cancer.
Joniau S; Abrahamsson PA; Bellmunt J; Figdor C; Hamdy F; Verhagen P; Vogelzang NJ; Wirth M; Van Poppel H; Osanto S
Eur Urol; 2012 Feb; 61(2):290-306. PubMed ID: 22001436
[TBL] [Abstract][Full Text] [Related]
14. Immunological challenges for peptide-based immunotherapy in glioblastoma.
Mohme M; Neidert MC; Regli L; Weller M; Martin R
Cancer Treat Rev; 2014 Mar; 40(2):248-58. PubMed ID: 24064197
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
16. Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma.
Csizmar CM; Ansell SM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804869
[TBL] [Abstract][Full Text] [Related]
17. Cancer therapy and vaccination.
Aly HA
J Immunol Methods; 2012 Aug; 382(1-2):1-23. PubMed ID: 22658969
[TBL] [Abstract][Full Text] [Related]
18. Vaccine strategies to treat lymphoproliferative disorders.
Radford KJ; Vari F; Hart DN
Pathology; 2005 Dec; 37(6):534-50. PubMed ID: 16373232
[TBL] [Abstract][Full Text] [Related]
19. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
[TBL] [Abstract][Full Text] [Related]
20. Immunizing against breast cancer: a new swing for an old sword.
Curigliano G; Locatelli M; Fumagalli L; Goldhirsch A
Breast; 2009 Oct; 18 Suppl 3():S51-4. PubMed ID: 19914543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]